The role of interleukin-17 in spondyloarthropathies and systemic lupus erythematosus: Two clinical cases in real
<p>Spondyloarthropathies are known to affect the interleukin (IL)-17 activation pathway as a basis of their pathology, as is apparent from the literature. Recent studies established the vital role of IL-17 in the treatment of Systemic Lupus Erythematosus (SLE). This article aims to demonstrate...
Saved in:
Main Authors: | Paula Antunes (Author), Rita Costa (Author), Ana Gorgulho (Author), António Marinho (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Medical and Clinical Case Reports - Peertechz Publications,
2022-01-19.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic Lupus Erythematosus
Published: (2012) -
Clinical Features and Long-Term Outcomes of Systemic Lupus Erythematosus
Published: (2023) -
Systemic Lupus Erythematosus Pathogenesis and Management
Published: (2023) -
Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Published: (2019) -
Role of dna methylation at herv sequence in systemic lupus erythematosus
by: Jeerawat Nakkuntod
Published: (2013)